The London Joint Working Group on Substance Use and Hepatitis C
LJWG was formed in 2009 to help drive improvements in the prevention, diagnosis and treatment of hepatitis C in people who use drugs in London.
We work together to improve outcomes for people with hepatitis C in this vulnerable population. The LJWG collaborates with stakeholders from the health service, providers, policy makers, pharmaceutical companies and service users.
THE LJWG 2023 ANNUAL CONFERENCE
We would like to say thank you to all of the speakers, guests and partner organisations who contributed to our conference on June 9th. It was vital to hear so many perspectives from those working in hepatitis C care, with lived experience, or both. You can watch videos of all four sessions of the conference on our YouTube channel or view the slides from the presentations here.
Watch our journey here:
What we do
We run pilot projects to improve hepatitis C diagnosis, care and treatment across London.
We produce reports to help people understand the wider challenges
and overcome barriers to addressing hepatitis C.
We create well-researched and tested resources for substance misuse services and people at risk of hepatitis C.